Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,714 public trials 622 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Active, Not Recruiting

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

NCT06718101

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Peak Dermatology Aesthetics and Wellness Fountain Hills /ID# 272550 Fountain Hills, Arizona, United States
  • Dermatology Research Associates - Los Angeles /ID# 272945 Los Angeles, California, United States
  • Integrative Skin Science and Research /ID# 274243 Sacramento, California, United States
  • Clinical Trials Research Institute /ID# 274234 Thousand Oaks, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

NCT07230860

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +8 more
Locations
  • First OC Dermatology Fountain Valley, California, United States
  • University of California Los Angeles - Division of Dermatology Los Angeles, California, United States
  • Southern California Dermatology Santa Ana, California, United States
  • Driven Research LLC Miami, Florida, United States
View all 62 locations
View Trial Details
Active, Not Recruiting

A 24-week rPMS Study in Real-world Setting for Enerzair

NCT05274425

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Daegu, Dalseo gu, South Korea
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

NCT05559359

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Research Trials North Little Rock, Arkansas, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 85 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

NCT05583227

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Los Angeles, California, United States
  • Research Site Aurora, Colorado, United States
View all 124 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

NCT07105488

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Mountain West Derm - Blackhart PLLC dba Skin Cancer and Dermatology Institute Phoenix, Arizona, United States
  • Skin Cancer and Dermatology Institute Phoenix, Arizona, United States
  • T. Joseph Raoof Md, Inc Encino, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
View all 88 locations
View Trial Details
Active, Not Recruiting

Fasenra Pediatric Japan Post-Marketing Study(PMS)

NCT06427876

Conditions
Asthma, Bronchial Asthma, Bronchial Diseases, +7 more
Locations
  • Research Site Aichi, Japan
  • Research Site Chiba, Japan
  • Research Site Hiroshima, Japan
  • Research Site Hokkaido, Japan
View Trial Details
Active, Not Recruiting

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

NCT06052267

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 15706 Birmingham, Alabama, United States
  • Teva Investigational Site 15786 Birmingham, Alabama, United States
  • Teva Investigational Site 15768 Dothan, Alabama, United States
  • Teva Investigational Site 15581 Paradise Valley, Arizona, United States
View all 393 locations
View Trial Details

Related conditions